Company Filing History:
Years Active: 2009
Title: Frederick James Bex, III: Innovator in Bone Mass Modulation
Introduction
Frederick James Bex, III is a notable inventor based in Newton Square, PA (US). He has made significant contributions to the field of biomedical research, particularly in the area of bone health. His work focuses on innovative methods to address bone mass modulation, which is crucial for treating conditions such as osteoporosis.
Latest Patents
Frederick holds a patent for a "Transgenic animal model of bone mass modulation." This invention relates to methods and materials used to express the HBM protein in animal cells and transgenic animals. It also encompasses transgenic animals that express the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The invention provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases related to bone development. In preferred embodiments, the invention is directed towards methods for treating, diagnosing, and preventing osteoporosis.
Career Highlights
Frederick is associated with Wyeth, a company known for its commitment to advancing healthcare through innovative solutions. His work at Wyeth has allowed him to contribute to groundbreaking research that has the potential to improve the quality of life for individuals suffering from bone-related diseases.
Collaborations
Frederick has collaborated with esteemed colleagues such as G Roger Askew and Philip Babij. These collaborations have further enriched his research and have led to advancements in the understanding of bone mass modulation.
Conclusion
Frederick James Bex, III is a distinguished inventor whose work in bone mass modulation has the potential to make a significant impact in the field of medicine. His innovative approaches and collaborations highlight the importance of research in developing effective treatments for osteoporosis and other bone-related conditions.